Seminars in Nephrology
Volume 25, Issue 1 , Pages 61-66 , January 2005

Uric acid in chronic heart failure

  • Wolfram Doehner

      Affiliations

    • Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow-Klinikum, Charite Medical School, Humboldt University, Berlin, Germany.
    • Corresponding Author InformationAddress reprint requests to Wolfram Doehner, MD, PhD, Department of Cardiology, Charité Campus Virchow-Klinikum, Augustenburger Platz 1, D-13353 Berlin, Germany.
    • ,
  • Stefan D. Anker

      Affiliations

    • Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow-Klinikum, Charite Medical School, Humboldt University, Berlin, Germany.
    • Department of Clinical Cardiology, National Heart & Lung Institute, Imperial College School of Medicine, London, UK.

References 

  1. Anker SD , Chua TP , Ponikowski P , et al.   Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia . Circulation . 1997;96:526–534
  2. Doehner W , Rauchhaus M , Florea VG , et al.   Uric acid in cachectic and non-cachectic CHF patients—relation to leg vascular resistance . Am Heart J . 2001;141:792–799
  3. Leyva F , Anker S , Swan JW , et al.   Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure . Eur Heart J . 1997;18:858–865
  4. McCord JM , Fridovich I . The reduction of cytochrome c by milk xanthine oxidase . J Biol Chem . 1968;243:5753–5760
  5. Terada LS , Guidot DM , Leff JA , et al.   Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity . Proc Natl Acad Sci U S A . 1992;89:3362–3366
  6. Harrison DG . Cellular and molecular mechanisms of endothelial cell dysfunction . J Clin Invest . 1997;100:2153–2157
  7. Cai H , Harrison DG . Endothelial dysfunction in cardiovascular disease . Circ Res . 1997;100:2153–2157
  8. Zweier JL , Kuppusamy P , Lutty GA . Measurement of endothelial cell free radical generation (Evidence for a central mechanism of free radical injury in postischemic tissues) . Proc Natl Acad Sci U S A . 1988;85:4046–4050
  9. McCord JM , Roy RS . The pathophysiology of superoxide (Roles in inflammation and ischemia) . Can J Physiol Pharmacol . 1982;60:1346–1352
  10. Braghiroli A , Sacco C , Erbetta M , et al.   Overnight urinary uric acid: Creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure . Am Rev Respir Dis . 1993;148:173–178
  11. Toguzov RT , Demin VF , Produkin VY , et al.   Influence of perinatal hypoxia on purine contents in erythrocytes of newborn infants . Biomed Biochim Acta . 1989;48:S279–S281
  12. Porter KB , O’Brien WF , Benoit R . Comparison of cord purine metabolites to maternal and neonatal variables of hypoxia . Obstet Gynecol . 1992;79:394–397
  13. Hayabuchi Y , Matsuoka S , Akita H , et al.   Hyperuricaemia in cyanotic congenital heart disease . Eur J Pediatr . 1993;152:873–876
  14. Marro PJ , Baumgart S , Delivoria-Papadopoulos M , et al.   Purine metabolism and inhibition of xanthine oxidase in severely hypoxic neonates going onto extracorporeal membrane oxygenation . Pediatr Res . 1997;41:513–520
  15. Woolliscroft JO , Colfer H , Fox IH . Hyperuricemia in acute illness (a poor prognostic sign) . Am J Med . 1982;72:58–62
  16. De Jong JW , van der Meer P , Huizer T , et al.   Does xanthine oxidase cause damage during myocardial ischemia? . Bratisl Lek Listy . 1991;92:41–47
  17. Huizer T , de Jong JW , Nelson JA , et al.   Urate production by human heart . J Mol Cell Cardiol . 1989;21:691–695
  18. Lazzarino G , Raatikainen P , Nuutinen M , et al.   Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery . Circulation . 1994;90:291–297
  19. Ashraf M , Samra ZQ . Subcellular distribution of xanthine oxidase during cardiac ischemia and reperfusion (an immunocytochemical study) . J Submicrosc Cytol Pathol . 1993;25:193–201
  20. Leyva F , Chua TP , Anker SD , et al.   Uric acid in chronic heart failure (A measure of the anaerobic threshold) . Metabolism . 1998;47:1156–1159
  21. Bakhtiiarov ZA . [Changes in xanthine oxidase activity in patients with circulatory failure] . Ter Arkh . 1989;61:68–69
  22. Doehner W , Tarpey MT , Pavitt DV , et al.   Elevated plasma xanthine oxidase activity in chronic heart failure (Source of increased oxygen radical load and effect of allopurinol in a placebo controlled, double blinded treatment study) . J Am Coll Cardiol . 2003;41(suppl A):207
  23. Landmesser U , Spiekermann S , Dikalov S , et al.   Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure (Role of xanthine-oxidase and extracellular superoxide dismutase) . Circulation . 2002;106:3073–3078
  24. Belch JJ , Bridges AB , Scott N , et al.   Oxygen free radicals and congestive heart failure . Br Heart J . 1991;65:245–248
  25. Ghatak A , Brar MJ , Agarwal A , et al.   Oxy free radical system in heart failure and therapeutic role of oral vitamin E . Int J Cardiol . 1996;57:119–127
  26. Keith M , Geranmayegan A , Sole MJ , et al.   Increased oxidative stress in patients with congestive heart failure . J Am Coll Cardiol . 1998;31:1352–2356
  27. Zelis R , Flaim SF . Alterations in vasomotor tone in congestive heart failure . Prog Cardiovasc Dis . 1982;24:437–459
  28. Anker SD , Swan JW , Volterrani M , et al.   The influence of muscle mass, strength, fatiguability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure . Eur Heart J . 1997;18:259–269
  29. Franciosa JA , Park M , Levine TB . Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure . Am J Cardiol . 1981;47:33–39
  30. Myers J , Fröhlicher VF . Hemodynamic determinants of exercise capacity in chronic heart failure . Ann Intern Med . 1991;15:377–386
  31. Sullivan MJ , Knight JD , Higginbotham MB , et al.   Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure . Circulation . 1989;80:769–781
  32. Drexler H , Hayoz D , Munzel T , et al.   Endothelial function in chronic congestive heart failure . Am J Cardiol . 1992;69:1596–1601
  33. Anker SD , Volterrani M , Egerer KR , et al.   Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure . QJM . 1998;91:199–203
  34. Keaney JF , Vita JA . Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action . Prog Cardiovasc Dis . 1995;38:129–154
  35. Indik JH , Goldman S , Gaballa MA . Oxidative stress contributes to vascular endothelial dysfunction in heart failure . Am J Physiol . 2001;281:H1767–H1770
  36. Jarasch ED , Grund C , Bruder G , et al.   Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium . Cell . 1981;25:67–82
  37. Jarasch ED , Bruder G , Heid HW . Significance of xanthine oxidase in capillary endothelial cells . Acta Physiol Scand Suppl . 1986;548:39–46
  38. Sarnesto A , Linder N , Raivio KO . Organ distribution and molecular forms of human xanthine dehydrogenase/xanthine oxidase protein . Lab Invest . 1996;74:48–56
  39. Tubaro E , Lotti B , Cavallo G , et al.   Liver xanthine oxidase increase in mice in three pathological models. A possible defence mechanism . Biochem Pharmacol . 1980;29:1939–1943
  40. McCord JM . The evolution of free radicals and oxidative stress . Am J Med . 2000;108:652–659
  41. Bolger AP , Anker SD . Tumour necrosis factor in chronic heart failure (A peripheral view on pathogenesis, clinical manifestations and therapeutic implications) . Drugs . 2000;60:1245–1257
  42. Adams V , Jiang H , Yu J , et al.   Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance . J Am Coll Cardiol . 1999;33:959–965
  43. Hornig B , Maier V , Drexler H . Physical training improves endothelial function in patients with chronic heart failure . Circulation . 1996;93:210–214
  44. Leyva F , Anker SD , Godsland I , et al.   Uric acid in chronic heart failure (A marker of chronic inflammation) . Eur Heart J . 1998;19:1814–1822
  45. Anker SD , Leyva F , Poole-Wilson PA , et al.   Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure . Heart . 1997;78:39–43
  46. Doehner W , Schoene N , Rauchhaus M , et al.   The effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure—results from two placebo controlled studies . Circulation . 2002;105:2619–2624
  47. Farquharson CA , Butler R , Hill A , et al.   Allopurinol improves endothelial dysfunction in chronic heart failure . Circulation . 2002;106:221–226
  48. Doehner W , Tarpey MT , Pavitt DV , et al.   Studies on plasma xanthine oxidase activity, marker of free radical production and effect of allopurinol in patients with chronic heart failure (CHF) . J Am Coll Cardiol . 2003;41(suppl):207A
  49. Butler R , Morris AD , Belch JJ , et al.   Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension . Hypertension . 2000;35:746–751
  50. Coghlan JG , Flitter WD , Clutton SM , et al.   Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting . J Thorac Cardiovasc Surg . 1994;107:248–256
  51. Waikakul S , Unnanantana A , Vanadurongwan V . The role of allopurinol in digital replantation . J Hand Surg . 1999;24B:325–327
  52. Ekelund UE , Harrison RW , Shokek O , et al.   Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure . Circ Res . 1999;85:437–445
  53. Ukai T , Cheng CP , Tachibana H , et al.   Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure . Circulation . 2001;103:750–755
  54. Saavedra WF , Paolocci N , St John ME , et al.   Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart . Circ Res . 2002;90:297–304
  55. Cappola TP , Kass DA , Nelson GS , et al.   Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy . Circulation . 2001;104:2407–2411
  56. Perez NG , Gao WD , Marban E . Novel myofilament Ca2+-sensitizing property of xanthine oxidase inhibitors . Circ Res . 1998;83:423–430
  57. Carlsen JE , Kober L , Torp-Pedersen C , et al.   Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects . BMJ . 1990;300:975–978
  58. Car N , Skrabalo Z , Verho M . The effects of piretanide in patients with congestive heart failure and diabetes mellitus (A double-blind comparison with furosemide) . Curr Med Res Opin . 1988;11:133–141
  59. Friedel HA , Buckley MM . Torasemide. A review of its pharmacological properties and therapeutic potential . Drugs . 1991;41:81–103
  60. Watanabe S , Kang DH , Feng L , et al.   Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity . Hypertension . 2002;40:355–360
  61. Rao GN , Corson MA , Berk BC . Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression . J Biol Chem . 1991;266:8604–8608
  62. Kang D-H , Nakagawa T , Feng L , et al.   A role for uric acid in the progression of renal disease . J Am Soc Nephrol . 2002;13:2888–2897
  63. Netea MG , Kullberg BJ , Blok WL , et al.   The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice . Blood . 1997;89:577–582
  64. Shi Y , Evans JE , Rock KL . Molecular identification of a danger signal that alerts the immune system to dying cells . Nature . 2003;425:516–521
  65. Anker SD , Doehner W , Rauchhaus M , et al.   Uric acid and survival in chronic heart failure (Validation and application in metabolic, functional, and hemodynamic staging) . Circulation . 2003;107:1991–1997
  66. Struthers AD , Donnan PT , Lindsay P , et al.   Effect of allopurinol on mortality and hospitalisations in chronic heart failure (A retrospective cohort study) . Heart . 2002;87:229–234

 Supported by the Verein der Freunde und Förderer der Berliner Charité, Germany; and the NHLI London (W.D.); and by the Vandervell Fellowship, London, UK, and a grant for Applied Cachexia Research by the Charite Medical School, Berlin, Germany (S.D.A.).

PII: S0270-9295(04)00153-6

doi: 10.1016/j.semnephrol.2004.09.010

Seminars in Nephrology
Volume 25, Issue 1 , Pages 61-66 , January 2005

Article Tools

* Image Usage & Resolution